首页> 外文OA文献 >Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor–Positive, HER-2/neu-Positive Breast Cancer

【2h】

Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor–Positive, HER-2/neu-Positive Breast Cancer

机译：患有雌激素受体阳性，HER-2 / Neu阳性乳腺癌模型中患者抗剥离和抗雌激素剥夺和氟斯坦的机制

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Suleiman Massarweh; C. Kent Osborne; Shou Jiang; Alan E. Wakeling; Mothaffar Rimawi; Syed K. Mohsin; Susan Hilsenbeck; Rachel Schiff;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Factors associated with prolonged post-recurrence survival in patients with postmenopausal estrogen receptor-positive breast cancer taking fulvestrant: A follow-up data of the JBCRG-C06 Safari study factors associated with prolonged post-recurrence survival in patients with postmenopausal estrogen receptor-positive breast cancer taking fulvestrant: A follow-up data of the JBCRGC-06 Safari study [J] . Intelligence: A Multidisciplinary Journal . 2020,第期

机译：患有氟斯特语的绝经后雌激素受体阳性乳腺癌患者长期复发后存活的因素患有富士群岛的癌症：JBCRGC-06 Safari研究的后续数据
2. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer [J] . Nikiana Simigdala, Qiong Gao, Sunil Pancholi, Breast Cancer Research . 2016,第1期

机译：胆固醇生物合成途径作为雌激素受体阳性乳腺癌雌激素剥夺抗性的新机制
3. High CDK6 Protects Cells from Fulvestrant-Mediated Apoptosis and is a Predictor of Resistance to Fulvestrant in Estrogen Receptor-Positive Metastatic Breast Cancer [J] . Alves Carla L., Elias Daniel, Lyng Maria, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第22期

机译：高CDK6保护细胞免受美沙芬特介导的细胞凋亡，并且是雌激素受体阳性转移性乳腺癌对美沙芬特耐药的预测因子。
4. Estrogen Receptor-Positive Breast Cancer: Traditional Prognostics, Molecular Pathology: A New Breast Cancer Taxonomy and 21st Century Personalized Prognostic and Predictive Assays [C] . Frederick L. Baehner International Symposium on Cancer Metastasis and the Lymphovascular system: Basis for Rational Therapy . 2009

机译：雌激素受体阳性乳腺癌：传统预测，分子病理：新的乳腺癌分类和21世纪个性化预测和预测测定
5. Overcoming Anti-Estrogen Resistance in Estrogen Receptor (ER)-Positive Breast Cancer: Rational Targeting of Phosphatidylinositol 3-Kinase (PI3K) and the Resurrection of Estrogen Therapy [D] . Hosford, Sarah 2018

机译：克服雌激素受体（ER）阳性乳腺癌中的抗雌激素抵抗：磷脂酰肌醇3-激酶（PI3K）的合理靶向和雌激素疗法的复活
6. Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs [O] . Ran Cheng, Liqiang Qi, Xiangyi Kong, 2020

机译：鉴定雌激素受体阳性乳腺癌中雌激素受体调节的重要基因及其表达模式发生时发生他莫昔芬或富含抗性抗性
7. Identification of the Significant Genes Regulated by Estrogen Receptor in Estrogen Receptor-Positive Breast Cancer and Their Expression Pattern Changes When Tamoxifen or Fulvestrant Resistance Occurs [O] . Ran Cheng, Liqiang Qi, Xiangyi Kong, 2020

机译：鉴定雌激素受体阳性乳腺癌中雌激素受体调节的重要基因及其表达模式发生时发生他莫昔芬或富含抗性抗性
8. Role of Smad4 on Tumorigenesis, ERK Pathway, and SERM Resistance in Estrogen Receptor Alpha-Positive Breast Carcinoma Cells; Annual summary rept. 30 Aug 2006-29 Aug 2007 [R] . Nichols, R. 2007

机译：smad4在雌激素受体α阳性乳腺癌细胞中的肿瘤发生，ERK信号通路和sERm抗性中的作用;年度总结报告。 2006年8月30日至2007年8月29日

Mechanisms of Tumor Regression and Resistance to Estrogen Deprivation and Fulvestrant in a Model of Estrogen Receptor–Positive, HER-2/neu-Positive Breast Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅